Expression of Epstein-Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine (Q45149270)

10 December 2017

Expression of Epstein-Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine (English)

1 reference

10 December 2017

0 references

Jackman WT

1

1 reference

10 December 2017

Mann KA

series ordinal

2

1 reference

10 December 2017

Hoffmann HJ

series ordinal

3

1 reference

10 December 2017

Spaete RR

series ordinal

4

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

10 December 2017

1 reference

10 December 2017

17

1 reference

10 December 2017

7-8

1 reference

10 December 2017

660-668

1 reference

Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen

10 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Validation of a first-generation Epstein-Barr virus vaccine preparation suitable for human use.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Transcription and DNA sequence of the BamHI L fragment of B95-8 Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Purification and quantification of recombinant Epstein-Barr viral glycoproteins gp350/220 from Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

2 New M13 vectors for cloning

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Antigenic analysis of the Epstein-Barr virus major membrane antigen (gp350/220) expressed in yeast and mammalian cells: implications for the development of a subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Epitope mapping of the major Epstein-Barr virus outer envelope glycoprotein gp350/220.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Expression of the Epstein-Barr virus major membrane proteins in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Truncated versions of the two major Epstein-Barr viral glycoproteins (gp250/350) are secreted by recombinant Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Mapping of the epitopes of Epstein--Barr virus gp350 using monoclonal antibodies and recombinant proteins expressed in Escherichia coli defines three antigenic determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Vero cell-expressed Epstein-Barr virus (EBV) gp350/220 protects marmosets from EBV challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900248-5

7 January 2021

10.1016/S0264-410X(98)00248-5

Identifiers

DOI

1 reference

10 December 2017

1 reference